1,4,7,10,13-Pentaazacyclohexadecane, cyclic peptide deriv. (53760-33-1)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Kallidin, cyclic (10®2)-peptide (9CI)
- 4-18-Atrial natriuretic peptide-21 (human reduced),N-(8-amino-1-oxooctyl)-,cyclic (18f4)-peptide
- 9,18-(Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1,2:8,9)(1,5,8,11,14)thiatetraazacyclooctadecino(18,17-b)indole, cyclic peptide deriv.
- 3-9-Phyllocaerulein(Agalychnis callidryas),N-acetyl-3-desulfo-4-[N6-(3-carboxy-1-oxopropyl)-L-lysine]-7-L-lysine-, cyclic(4®7)-peptide (9CI)
- Glycine,N-(2-pyrrolidinylmethyl)glycyl-D-phenylalanyl-L-prolyl-, cyclic (4®1)-peptide, (S)- (9CI)
- L-Serine, N2 -(7-amino-1-oxoheptyl)-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-, cyclic (10-1)-peptide
- AZASERINE, CYCLIC PEPTIDE (TRANS)
- AZASERINE, CYCLIC PEPTIDE (CIS)
- bimol. cyclic peptide ;;
- Annosquamosin A (cyclic peptide)
- cyclic dibutylstannylene deriv. ;;
- L-Threonine,N-[[4-(aminomethyl)phenyl]acetyl]-L-phenylalanyl-D-tryptophyl-L-lysyl-, cyclic(4®1)-peptide (9CI)
- Oxytocin,1-(3-mercaptopropanoic acid)-4-L-glutamic acid-8-L-lysine-, cyclic (4®8)-peptide (9CI)
- L-Tyrosinamide,L-cysteinyl-L-lysyl-L-arginylglycyl-L-prolylglycyl-L-seryl-L-a-aspartyl-L-phenylalanyl-L-a-aspartyl-, cyclic (10®1)-peptide (9CI)
- L-Threonine,N-[[3-(aminomethyl)phenyl]acetyl]-L-phenylalanyl-D-tryptophyl-L-lysyl-, cyclic(4®1)-peptide (9CI)
- L-Leucine,glycylglycyl-4-[[5-(2-amino-2-carboxyethyl)-2-hydroxyphenyl]azo]-L-phenylalanyl-,cyclic (3®1)-peptide (9CI)
- Glycine,N-[[2-(1-aminoethyl)-4-thiazolyl]- carbonyl]tryptophyl-5-methoxytryptophylglycyl- 2-aminobutanoyl-2,3-didehydroalanyl-Nmethyl-,cyclic (6f1)-peptide
- Hexadecanoic acid,cyclic methylene deriv.
- Amines, cyclic,piperazine deriv.-rich
- Glycinamide, L-a-glutamyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valyl-,cyclic (1®7)-peptide (9CI)